MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Sotera Health Company Total Liabilities 2011-2026 | SHC
Annual Total Liabilities Sotera Health Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.67 B | 2.69 B | 2.77 B | 2.2 B | 2.31 B | 3.22 B | 2.66 B | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.22 B | 2.2 B | 2.65 B |
Quarterly Total Liabilities Sotera Health Company
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.64 B | 2.71 B | 2.68 B | 2.68 B | 2.64 B | 2.63 B | 2.66 B | 2.66 B | 3.05 B | 2.77 B | 2.2 B | - | 2.19 B | 2.2 B | 2.22 B | 2.33 B | 2.31 B | 2.31 B | 2.31 B | 2.31 B | 2.31 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.05 B | 2.19 B | 2.49 B |
Total Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Anixa Biosciences
ANIX
|
2.13 M | $ 3.03 | -2.26 % | $ 98.3 K |  USA |
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | USA |
 |
Brainsway Ltd.
BWAY
|
14.4 M | $ 23.35 | -2.91 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 34.5 | 2.16 % | $ 371 M |  China |
 |
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.29 | -12.26 % | $ 1.64 M | USA |
 |
Castle Biosciences
CSTL
|
75.4 M | $ 39.74 | 1.48 % | $ 1.1 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
9.31 M | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
31.8 B | $ 219.29 | -0.08 % | $ 160 B | USA |
 |
Exact Sciences Corporation
EXAS
|
3.53 B | $ 102.41 | 0.1 % | $ 19 B | USA |
 |
Fulgent Genetics
FLGT
|
90.8 M | $ 26.19 | -0.19 % | $ 792 M | USA |
 |
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | China |
 |
Guardant Health
GH
|
1.63 B | $ 113.17 | 2.43 % | $ 13.9 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
4.2 B | $ 73.31 | -0.93 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
205 M | $ 20.55 | -1.23 % | $ 1.1 B | USA |
 |
Celcuity
CELC
|
130 M | $ 109.48 | -2.35 % | $ 4.32 B | USA |
 |
DarioHealth Corp.
DRIO
|
7.26 M | $ 10.2 | -0.97 % | $ 289 M | Israel |
 |
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
892 M | $ 66.91 | 0.34 % | $ 4.63 B | USA |
 |
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
2.7 B | $ 144.81 | -3.26 % | $ 23 B | USA |
 |
NeoGenomics
NEO
|
736 M | $ 11.99 | -3.35 % | $ 1.52 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.11 B | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
20.8 B | $ 230.33 | -2.19 % | $ 41.8 B | USA |
 |
Charles River Laboratories International
CRL
|
4.02 B | $ 210.51 | -0.59 % | $ 10.8 B | USA |
 |
Personalis
PSNL
|
67.3 M | $ 9.33 | -6.42 % | $ 553 M | USA |
 |
Medpace Holdings
MEDP
|
1.28 B | $ 582.66 | -1.76 % | $ 18 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 186.45 | 2.27 % | $ 20.7 B | USA |
|
Biodesix
BDSX
|
76.4 M | $ 10.11 | 4.66 % | $ 1.31 B | USA |
 |
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
3.67 M | $ 24.07 | -0.78 % | $ 31.2 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.3 B | $ 271.34 | 0.56 % | $ 22.8 B | USA |
 |
Mettler-Toledo International
MTD
|
3.37 B | $ 1 370.47 | -1.61 % | $ 29.1 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
7.35 B | $ 181.44 | -2.39 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.7 B | $ 672.84 | -0.57 % | $ 55.5 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
16.9 B | $ 28.66 | -2.02 % | $ 20 B | Niderland |
 |
Agilent Technologies
A
|
5.32 B | $ 133.33 | 0.07 % | $ 40.5 B | USA |
 |
Biomerica
BMRA
|
1.84 M | $ 2.41 | 0.84 % | $ 5.54 M | USA |